Australians that are struggling to get a good night sleep can now screen their likelihood of suffering from sleep apnoea with medtech company ResApp Health (ASX: RAP) having launched their clinically tested SleepCheck app on the iPhone App Store. By downloading the smartphone app, SleepCheck can record and analyse breaking and snorting sounds during sleep
Read More
Global pharmaceutics and cannabis healthcare company Althea Group (ASX: AGH) has harnessed the power of telehealth through COVID-19, almost doubling web-based enquiries for their MyAccess Clinics in the UK where patients can seek medicinal cannabis treatment pathways. With the England being one of the harder nations hit by COVID-19, Althea accelerated telehealth offerings for its
Read More
Australian medtech company Mach7 Technologies (ASX: M7T) has continued to strengthen its position in the Hong Kong market, securing new licencing orders of $4.8m, adding to their existing 5-year contract to supply medical imaging solutions to the entire territory of Hong Kong. The new AUD $4.8m is expected to be logged as cash collected within
Read More
Allied health services group Healthia (ASX: HLA) has continued its expansion as Australia’s largest operator podiatry clinics, today announcing the acquisition of 12 clinics in Victoria to significantly expand its healthcare offerings in the State. Secured for a total consideration of $5 million, the 12 new clinics are forecast to deliver Healthia with $4.4m revenue
Read More
Microcap AI and prescriptive analytics company Houston we Have (ASX: HWH) has hit the ground running since rebranding and expediting an entry into the healthcare AI sector. Although the contracts are collectively only expected to add $130k of revenue to Houston, it opens up significant market opportunities which have been brought upon by their acquisition
Read More
Prior to COVID-19 bringing attention to the value of telehealth, HeraMED (ASX: HMD) has been building digital infrastructure to revolutionise the maternal healthcare market with their screening and remote midwife platform which is preparing to now enter the lucrative U.S market. The expansion into the world’s most lucrative healthcare market, valued at USD $111 billion
Read More